Grants and Contributions

The specific objectives of this funding opportunity are to:

Generate data and evidence to monitor and evaluate the potential benefits, harms, and unintended consequences of alcohol regulation on population health and health equity;
Generate intervention-related evidence to address the needs of knowledge users in this space, including for regulatory aims;
Facilitate consideration and application of new evidence to inform ongoing and future development of policies, practices and programs related to alcohol;
Support partnerships between researchers and knowledge users to rapidly inform policies and practices related to prevention, harm reduction, and treatment of alcohol use;
Encourage evaluation of interventions, population health intervention research, and implementation science approaches that consider sub-populations and/or the biological, structural, and social determinants of problematic alcohol use.

• Canada’s Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care. Its vision is that by 2025, Canada will have demonstrably improved health outcomes and enhanced the health care experience for patients through the integration of evidence at all levels of the health care system.
• As outlined in the SPOR Patient Engagement Framework, patient-oriented research refers to a continuum of research that engages patients as partners, focusses on patient-identified priorities and improves patient outcomes. This research, conducted by multidisciplinary teams in partnership with relevant stakeholders, aims to apply the knowledge generated to improve healthcare systems and practices.
• As a partner in SPOR, CIHR will provide bridge funding for fundable applications that are below the competition funding cut-off and aligned with the SPOR vision, the SPOR Patient Engagement Framework and the SPOR Capacity Development Framework. Categories are described in the Funds Available section.

• Canada’s Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care. Its vision is that by 2025, Canada will have demonstrably improved health outcomes and enhanced the health care experience for patients through the integration of evidence at all levels of the health care system.
• As outlined in the SPOR Patient Engagement Framework, patient-oriented research refers to a continuum of research that engages patients as partners, focusses on patient-identified priorities and improves patient outcomes. This research, conducted by multidisciplinary teams in partnership with relevant stakeholders, aims to apply the knowledge generated to improve healthcare systems and practices.
• As a partner in SPOR, CIHR will provide bridge funding for fundable applications that are below the competition funding cut-off and aligned with the SPOR vision, the SPOR Patient Engagement Framework and the SPOR Capacity Development Framework. Categories are described in the Funds Available section.

• Canada’s Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care. Its vision is that by 2025, Canada will have demonstrably improved health outcomes and enhanced the health care experience for patients through the integration of evidence at all levels of the health care system.
• As outlined in the SPOR Patient Engagement Framework, patient-oriented research refers to a continuum of research that engages patients as partners, focusses on patient-identified priorities and improves patient outcomes. This research, conducted by multidisciplinary teams in partnership with relevant stakeholders, aims to apply the knowledge generated to improve healthcare systems and practices.
• As a partner in SPOR, CIHR will provide bridge funding for fundable applications that are below the competition funding cut-off and aligned with the SPOR vision, the SPOR Patient Engagement Framework and the SPOR Capacity Development Framework. Categories are described in the Funds Available section.

Flood made tremendous contributions towards advancing the field of health services and policy research in Canada, building a community of world-class researchers, and designing innovative new programs that foster evidence-informed decision making and improved health and health care for Canadians

• The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined to be relevant to the mandate and research priority areas of CIHR-IMHA as described below:
o Myalgic Encephalomyelitis (ME)
o IMHA Mandate Areas:
¿ Musculoskeletal Health
¿ Skin Health
¿ Oral Health
¿ Chronic Pain and Fatigue
¿ Inflammation and Tissue Repair
¿ Disability, Mobility and Health

• The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined to be relevant to the mandate and research priority areas of CIHR-IMHA as described below:
o Myalgic Encephalomyelitis (ME)
o IMHA Mandate Areas:
¿ Musculoskeletal Health
¿ Skin Health
¿ Oral Health
¿ Chronic Pain and Fatigue
¿ Inflammation and Tissue Repair
¿ Disability, Mobility and Health

The CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) will provide funding for applications in which the objectives and aims are determined to be largely and directly relevant to the INMD mandate as described below:
o CIHR-INMD supports research to enhance health in relation to diet, digestion, excretion, and metabolism; and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions and problems associated with hormone, digestive system, kidney, and liver.
• These grants afford principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees.

IPPH is particularly interested in projects exploring the compounding influences of AI on public health at the intersections of various social determinants of health, including but not limited to sex and gender, race, ethnicity, Indigenous identity, and disability.

The specific objectives of this funding opportunity are to:

• Generate relevant and timely evidence about the impacts of innovations in how healthcare systems and services are organized, delivered, governed, held accountable, financed, and/or funded on the Quadruple Aim goals and equity, and which innovations have the most potential for transformative impact in the Canadian context;
• Respond to a policy and/or decision maker’s evidence needs and help to inform decisions, policies or actions that advance achievement of the Quadruple Aim goals and health equity for all; and
• Catalyze future transformative, collaborative research between researchers, policy and/or decision makers, healthcare providers and patients that can be pursued through CIHR’s Project Grant competition or other relevant strategic funding competitions.